Phio Pharmaceuticals Corp. (PHIO) Financial Statements (2024 and earlier)

Company Profile

Business Address 11 APEX DRIVE, SUITE 300A
MARLBOROUGH, MA 01752
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments11,78124,05714,2446,93414,8793,581
Cash and cash equivalents11,78124,05714,2446,93414,8793,581
Restricted cash and investments      50
Other undisclosed current assets665670920366271201
Total current assets:12,44624,72715,1647,30015,1503,832
Noncurrent Assets
Operating lease, right-of-use asset161283400511
Property, plant and equipment183133157210172248
Other noncurrent assets24271818 18
Total noncurrent assets:368443575739172266
TOTAL ASSETS:12,81425,17015,7398,03915,3224,098
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,8042,9432,0801,7731,7442,265
Accounts payable779283728809550511
Accrued liabilities1,0252,6601,3529641,1941,754
Debt    107  
Other undisclosed current liabilities135125116   
Total current liabilities:1,9393,0682,1961,8801,7442,265
Noncurrent Liabilities
Long-term debt and lease obligation  170526411  
Long-term debt, excluding current maturities   231   
Liabilities, other than long-term debt 35     
Operating lease, liability 35170295411
Other undisclosed noncurrent liabilities  (170)(295)   
Total noncurrent liabilities: 35170526411  
Total liabilities:1,9743,2382,7222,2911,7442,265
Equity
Equity, attributable to parent10,83821,93213,0175,74813,5781,833
Common stock  1112 
Additional paid in capital139,218138,831116,629100,56699,48780,384
Accumulated deficit(128,380)(116,900)(103,613)(94,819)(85,911)(78,551)
Other undisclosed equity 2     
Total equity:10,84021,93213,0175,74813,5781,833
TOTAL LIABILITIES AND EQUITY:12,81425,17015,7398,03915,3224,098

Income Statement (P&L) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues    2113815
Gross profit:    2113815
Operating expenses(11,462)(13,511)(8,793)(9,008)(7,502)(14,077)
Operating loss:(11,462)(13,511)(8,793)(8,987)(7,364)(14,062)
Nonoperating income (expense)(18)224(1)794(11)
Other nonoperating expense      (10)
Interest and debt expense  233    
Loss from continuing operations before equity method investments, income taxes:(11,480)(13,054)(8,794)(8,908)(7,360)(14,073)
Other undisclosed loss from continuing operations before income taxes  (233)    
Loss from continuing operations before income taxes:(11,480)(13,287)(8,794)(8,908)(7,360)(14,073)
Income tax benefit   2,6412,5322,1941,621
Loss from continuing operations:(11,480)(13,287)(6,153)(6,376)(5,166)(12,452)
Loss before gain (loss) on sale of properties:(13,287)(6,153)(6,376)(5,166)(12,452)
Net loss:(11,480)(13,287)(6,153)(6,376)(5,166)(12,452)
Other undisclosed net loss attributable to parent   (2,641)(2,532)(2,194) 
Net loss available to common stockholders, diluted:(11,480)(13,287)(8,794)(8,908)(7,360)(12,452)

Comprehensive Income ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(11,480)(13,287)(6,153)(6,376)(5,166)(12,452)
Comprehensive loss, net of tax, attributable to parent:(11,480)(13,287)(6,153)(6,376)(5,166)(12,452)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: